Abstract

Background: Patients on hemodialysis are at high risk of adverse cardiac events after coronary artery bypass grafting (CABG). The aim of this study is to know whether CABG with complete revascularization and similar graft selection can provide equivalent long-term benefits for patients on and not on hemodialysis. Methods: Between 2004 and 2018, 746 patients underwent isolated CABG, of which 106 were on hemodialysis. Propensity matching on baseline characteristics, graft types and on/off-pump CABG was performed to compare clinical outcomes between patients on (n = 102) and not on (n = 102) hemodialysis. Results: Complete revascularization was achieved in all patients. The mean follow-up was 112.5 ± 46.6 months. Off-pump rates (hemodialysis vs non-hemodialysis, 93/102 vs 94/102, p > 0.999) and graft selections (distal anastomoses: 3.7 ± 1.4 vs 3.8 ± 1.5, p = 0.377, ITA grafts: 1.4 ± 0.6 vs 1.5 ± 0.6, p = 0.560, arterial grafts: 1.9 ± 0.9 vs 2.0 ± 0.8, p = 0.658, vein grafts: 0.69 ± 0.63 vs 0.65 ± 0.70, p = 0.513) were well balanced between the groups. Hospital mortality was higher in patients on hemodialysis than in those not on hemodialysis (5/102 vs 1/102, p = 0.212). The Kaplan-Meier analysis revealed that cardiac death (without non-cardiac causes) was significantly more common in patients on hemodialysis than in those not on hemodialysis (p = 0.018). However, there were no significant differences in deaths due to ischemic heart disease (p = 0.327), repeated revascularization (p = 0.542), myocardial infarction (p = 0.783), and heart failure requiring admission (p = 0.371). Conclusion: CABG with complete revascularization and similar graft selection provides equivalent long-term benefits with regard to the prevention of adverse cardiac events due to ischemic heart disease in patients on and not on hemodialysis.

Highlights

  • Life expectancy is lower among patients on hemodialysis than among people without kidney disease, and approximately half of the patients on hemodialysis die from cardiovascular diseases [1]

  • Ventilation time, intensive care unit stay, and hospital stay were significantly longer in patients on hemodialysis than in those not on hemodialysis (Table 3)

  • Five deaths occurred among patients on hemodialysis, and they were related to heart failure (n = 2), sepsis (n = 2), and peripheral arterial disease (n = 1)

Read more

Summary

Introduction

Life expectancy is lower among patients on hemodialysis than among people without kidney disease, and approximately half of the patients on hemodialysis die from cardiovascular diseases [1]. Coronary artery bypass grafting (CABG) plays an important role in maintaining the life of patients on hemodialysis. Numerous studies have demonstrated a high incidence of adverse cardiac events in the early stage and in the long-term after CABG among patients on hemodialysis [3] [4]. Marui et al reported on the 5-year outcomes of CABG among patients on hemodialysis and mentioned that the rates of repeated coronary revascularization and cardiac death in these patients were about twice as high as those in patients undergoing general CABG [6] [7]. Patients on hemodialysis are at high risk of adverse cardiac events after coronary artery bypass grafting (CABG). The aim of this study is to know whether CABG with complete revascularization and similar graft selection can provide equivalent long-term benefits for patients on and not on hemodialysis.

Objectives
Methods
Results
Discussion
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call